Literature DB >> 10600404

Microglial activation and neurological symptoms in the SIV model of NeuroAIDS: association of MHC-II and MMP-9 expression with behavioral deficits and evoked potential changes.

N E Berman1, J K Marcario, C Yong, R Raghavan, L A Raymond, S V Joag, O Narayan, P D Cheney.   

Abstract

HIV-1 causes cognitive and motor deficits and HIV encephalitis (HIVE) in a significant proportion of AIDS patients. Neurological impairment and HIVE are thought to result from release of cytokines and other harmful substances from infected, activated microglia. In this study, the quantitative relationship between microglial activation and neurological impairment was examined in the simian immunodeficiency model of HIVE. Macaque monkeys were infected with a passaged, neurovirulent strain of simian immunodeficiency virus, SIV(mac)239(R71/17E). In concurrent studies, functional impairment was assessed by motor and auditory brainstem evoked potentials and by measurements of cognitive and motor behavioral deficits. Brain tissue was examined by immunohistochemistry using two markers of microglia activation, MHC-II and matrix metalloproteinase-9 (MMP-9). The inoculated animals formed two groups: rapid progressors, which survived 6-14 weeks postinoculation, and slow progressors, which survived 87-109 weeks. In the rapid progressors, two patterns of MHC-II expression were present: (1) a widely disseminated pattern of MHC-II expressing microglia and microglial nodules in cortical gray matter and subcortical white matter, and (2) a more focal pattern in which MHC-II expressing microglia were concentrated into white matter. Animals exhibiting both patterns of microglial activation showed mild to severe changes in cognitive and motor behavior and evoked potentials. All rapid progressors showed expression of MMP-9 in microglia located in subcortical white matter. In the slow progressors MHC-II and MMP-9 staining was similar to uninoculated control macaques, and there was little or no evidence of HIVE. These animals showed behavioral deficits at the end of the disease course, but little changes in evoked potentials. Thus, increases in MHC-II and MMP-9 expression are associated with development of cognitive and motor deficits, alterations in evoked potentials, and rapid disease progression. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10600404     DOI: 10.1006/nbdi.1999.0261

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  24 in total

Review 1.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

2.  Exacerbated glial response in the aged mouse hippocampus following controlled cortical impact injury.

Authors:  Rajat Sandhir; Gregory Onyszchuk; Nancy E J Berman
Journal:  Exp Neurol       Date:  2008-07-02       Impact factor: 5.330

Review 3.  GPR18 in microglia: implications for the CNS and endocannabinoid system signalling.

Authors:  D McHugh
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

4.  Multiple expression of matrix metalloproteinases in murine neurocysticercosis: Implications for leukocyte migration through multiple central nervous system barriers.

Authors:  Jorge I Alvarez; Judy M Teale
Journal:  Brain Res       Date:  2008-04-01       Impact factor: 3.252

5.  Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat.

Authors:  Daniel Fraga; Erinn S Raborn; Gabriela A Ferreira; Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-07       Impact factor: 4.147

6.  Effects of aging on blood brain barrier and matrix metalloproteases following controlled cortical impact in mice.

Authors:  Phil Lee; Jieun Kim; Rachel Williams; Rajat Sandhir; Eugene Gregory; William M Brooks; Nancy E J Berman
Journal:  Exp Neurol       Date:  2011-12-19       Impact factor: 5.330

7.  Lentivirus infection in the brain induces matrix metalloproteinase expression: role of envelope diversity.

Authors:  J B Johnston; Y Jiang; G van Marle; M B Mayne; W Ni; J Holden; J C McArthur; C Power
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  Global gray and white matter metabolic changes after simian immunodeficiency virus infection in CD8-depleted rhesus macaques: proton MRS imaging at 3 T.

Authors:  William E Wu; Assaf Tal; Ivan I Kirov; Henry Rusinek; Daniel Charytonowicz; James S Babb; Eva-Maria Ratai; R Gilberto Gonzalez; Oded Gonen
Journal:  NMR Biomed       Date:  2013-02-17       Impact factor: 4.044

9.  HIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stress.

Authors:  Jean-Pierre Louboutin; Lokesh Agrawal; Beverly A S Reyes; Elisabeth J Van Bockstaele; David S Strayer
Journal:  J Neuropathol Exp Neurol       Date:  2010-08       Impact factor: 3.685

10.  Novel role of TGF-beta in differential astrocyte-TIMP-1 regulation: implications for HIV-1-dementia and neuroinflammation.

Authors:  Alok Dhar; Jessica Gardner; Kathleen Borgmann; Li Wu; Anuja Ghorpade
Journal:  J Neurosci Res       Date:  2006-05-15       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.